Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics
The current global COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in a public health crisis with more than 168 million cases reported globally and more than 4.5 million deaths at the time of writing. In addition to the direct impact of the disea...
Main Authors: | Robert V. House, Thomas A. Broge, Todd J. Suscovich, Doris M. Snow, Milan T. Tomic, Genevieve Nonet, Kamaljit Bajwa, Guangyu Zhu, Zachary Martinez, Kyal Hackett, Christopher G. Earnhart, Nicole M. Dorsey, Svetlana A. Hopkins, Dalia S. Natour, Heather D. Davis, Michael S. Anderson, Melicia R. Gainey, Ronald R. Cobb |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165815/?tool=EBI |
Similar Items
-
Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics.
by: Robert V House, et al.
Published: (2022-01-01) -
Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model
by: Milan T. Tomic, et al.
Published: (2019-04-01) -
A monoclonal antibody toolkit for C. elegans.
by: Gayla Hadwiger, et al.
Published: (2010-04-01) -
A Monoclonal Antibody Combination against both Serotypes A and B Botulinum Toxin Prevents Inhalational Botulism in a Guinea Pig Model
by: Doris M. Snow, et al.
Published: (2021-01-01) -
Is intensive care the only answer for high risk pregnancies in developing nations?
by: Bajwa Sukhwinder, et al.
Published: (2010-01-01)